Hypokalemic rhabdomyolysis and schizophrenia

Authors

  • Natalia Fantacone Médica psiquiatra. Hospital Tornú. JTP de Salud Mental, Unidad Académica Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA
  • Edgardo Carísimo Médico psiquiatra. JTP Salud Mental. Unidad Académica Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA Servicio de Neurología del Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA
  • Pablo Landi Médico especialista en Clínica Médica y Gerontología. Doctor en Medicina. JTP de la UDH Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA
  • Eden Del Mar Walsöe Médica Residente del Servicio de Clínica Médica. Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA
  • Daniel Fadel Médico especialista en psiquiatría. Jefe de Servicio de Psiquiatría y Salud Mental. Instituto de Investigaciones Médicas “A. Lanari”. Docente Adscripto de la Iª Cátedra de Farmacología. Facultad de Medicina, UBA. Director del Curso de Posgrado Avanzado: “Bases Neurobiológicas y Farmacológicas de la Terapéutica Psiquiátrica 2015”, Facultad de Medicina, UBA Servicio de Psiquiatría y Salud Mental, Instituto de Investigaciones Médicas “A. Lanari”, Facultad de Medicina, UBA

Keywords:

Rhabdomyolysis., Hypokalemia, Schizophrenia, Creatine, Substance abuse

Abstract

The purpose of this report is to emphasize the necessity to periodically explore internal environment variables, as certain metabolic alterations often go unnoticed during antipsychotic treatment. Early detection of such alterations may prevent catastrophic syndromes. We will also stress the clinical relevance of cognitive perseverations in schizophrenic patients, as these often condition habits of consumption which can alter the internal environment. In this clinical case of a schizophrenic patient, a chain of events led to a catastrophic syndrome: a trivial home accident (fall from own height) developed into a condition characterized by oligoanuria, hypokalemia, creatine phosphokinase (CPK) elevation (125,000 IU / L) and acute renal failure with dialysis requirement. This episode was non lethal due to the early implementation of support measures. We performed a revision of the available literature in order to discern the cause of the elevation of CPK. Here we aim to highlight the importance of 1) careful clinical and laboratory monitoring of psychopharmacological treatment, 2) interactions resulting from consumption habits capable of generating unforeseen consequences, 3) the role of the psychiatrist in the context of multidisciplinary work.

Downloads

Download data is not yet available.

Published

2017-09-10

How to Cite

Fantacone , N. ., Carísimo, E., Landi, P., Walsöe, E. D. M., & Fadel, D. (2017). Hypokalemic rhabdomyolysis and schizophrenia. Vertex Revista Argentina De Psiquiatría, 28(134, jul.-ago.), 271–279. Retrieved from https://revistavertex.com.ar/ojs/index.php/vertex/article/view/439